Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer

PURPOSE: The clinical management of patients with castration-resistant prostate cancer (CRPC) is difficult. However, novel treatment methods are gradually being introduced. Considering the adverse effects of traditional treatments, recent studies have investigated gene therapy as a method to combat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tai, Zongguang, Ma, Jinyuan, Ding, Jianing, Pan, Huijun, Chai, Rongrong, Zhu, Congcong, Cui, Zhen, Chen, Zhongjian, Zhu, Quangang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759727/
https://www.ncbi.nlm.nih.gov/pubmed/33376323
http://dx.doi.org/10.2147/IJN.S282107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759727/
https://www.ncbi.nlm.nih.gov/pubmed/33376323
http://dx.doi.org/10.2147/IJN.S282107

Ejemplares similares